Norovirus capsid and rotavirus VP6 protein for use as combined vaccine
US8895015B2 · kind B2 · utility
1Cited by
2References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 7, 2011 |
| Grant date | Nov 25, 2014 |
| Priority date | — |
| Expiry date | May 27, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2800/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a combined norovirus and rotavirus vaccine for prevention of norovirus and rotavirus infection and/or viral-induced diarrheal and vomiting diseases in man. More specifically, the invention comprises a method of preparing combination vaccine compositions comprising norovirus and rotavirus antigens, in particular mixtures of norovirus VLPs and rotavirus recombinant VP6 protein or double-layered VP2/VP6 VLPs. In addition, the invention relates to methods of inducing an immune response.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.